Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue BioMed Research International Année : 2016

Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study

Résumé

In this study, mitoxantrone and its halogenated derivatives have been designed by density functional theory (DFT) to explore their structural and thermodynamical properties. The performance of these drugs was also evaluated to inhibit DNA topoisomerase type II (TOP2A) by molecular docking calculation. Noncovalent interactions play significant role in improving the performance of halogenated drugs. The combined quantum and molecular mechanics calculations revealed that CF 3 containing drug shows better preference in inhibiting the TOP2A compared to other modified drugs.
Fichier principal
Vignette du fichier
6817502.pdf (1.9 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02304947 , version 1 (10-02-2021)

Identifiants

Citer

Md. Abu Saleh, Md. Solayman, Mohammad Mazharol Hoque, Mohammad A. K. Khan, Mohammed G. Sarwar, et al.. Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study. BioMed Research International , 2016, 2016, pp.6817502. ⟨10.1155/2016/6817502⟩. ⟨hal-02304947⟩
24 Consultations
57 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More